To meet this urgent demand, LabCorp Employer Services provides customized return to work solutions using LabCorp’s trained medical staff for employee check-in health questionnaires, temperature screens, and COVID-19 test collection at the employer site or offsite
LabCorp announced today it is launching a new return to work service for employers. Many U.S. companies have asked for LabCorp’s assistance as they implement their return to work strategies for the summer and fall.
To meet this urgent demand, LabCorp Employer Services provides customized return to work solutions using LabCorp’s trained medical staff for employee check-in health questionnaires, temperature screens, and COVID-19 test collection at the employer site or offsite. The service gives employers access to LabCorp’s COVID-19 testing solutions including its at-home collection test kit, its new fingerstick antibody blood test, and in the fall, flu vaccination services.
“We have been helping keep people safe and healthy for 50 years and are uniquely positioned to assist employers in their return to work strategies,” Dr. Brian Caveney, chief medical officer and president of LabCorp Diagnostics. “Through science and research, LabCorp’s diagnostic testing capabilities set the industry standard in quality and accuracy. Employer Services is another example of our commitment to being an integral part of the solution to this health crisis.”
LabCorp’s new convenient fingerstick antibody blood test detects IgG antibodies to the virus that causes COVID-19 and provides highly specific results equivalent to LabCorp’s other antibody blood testing methods. Fingerstick IgG antibody testing provides a convenient way to test large numbers of employees as part of return to work programs.
LabCorp’s fingerstick, or dried blood spot, IgG antibody test is being provided as a laboratory developed test, and uses the EUROIMMUN test which received Emergency Use Authorization by the U.S. Food and Drug Administration. LabCorp completed independent validation studies on this testing. The COVID-19 IgG antibody blood test detects the presence of antibodies to the virus and can help determine if an individual may have been exposed to the virus. While antibody tests are helpful to understand if an individual has developed antibodies and a potential immune response, antibody testing should not be used as the sole basis to diagnose or exclude infection.
LabCorp Employer Services was previously called Wellness Corporate Solutions. In addition to LabCorp’s COVID-19 testing and flu vaccination services, LabCorp Employer Services offers comprehensive wellness solutions, including biometric screening, occupational testing, and diagnostic services.
Source: Company Press Release